Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Drug-related pneumonitis (DRP) caused by epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors (TKIs) is a fatal adverse event in patients with EGFR-mutant non-small cell lung cancer (NSCLC). The diagnosis of DRP is based on radiological findings, the temporal association of presentation with the initiation of a systemic therapeutic agent, and the exclusion of other likely causes. Here we report a case in which severe adenoviral pneumonia mimicking DRP occurred during treatment with osimertinib, and osimertinib was successfully resumed after recovery from adenoviral pneumonia.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10961219 | PMC |
| http://dx.doi.org/10.1111/1759-7714.15250 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Red yeast rice-induced severe rhabdomyolysis complicated by acute kidney injury and respiratory failure: a case report.
Front Med (Lausanne)
August 2025
Department of Emergency Medicine, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China.
Red yeast rice (RYR), a commonly used supplement with statin-like properties, is generally considered safe but may cause severe adverse effects such as rhabdomyolysis. We report a rare case of severe RYR-induced rhabdomyolysis complicated by acute kidney injury (AKI) and respiratory failure, with diaphragmatic dysfunction as a key contributing factor. A 78-year-old woman developed progressive proximal muscle weakness, dyspnea, and tea-colored urine after taking RYR (2 g/day) for 1 month.
View Article and Find Full Text PDFBilateral globus pallidus lesions associated with COVID-19: Mimicking acute carbon monoxide poisoning.
Medicine (Baltimore)
August 2025
Department of Radiology, Chungbuk National University Hospital, Cheongju, Republic of Korea.
Rationale: Bilateral symmetrical globus pallidus (GP) involvement associated with coronavirus disease 2019 (COVID-19) infection is an extremely rare finding among cases of COVID-19-related encephalopathy.
Patient Concerns: A 76-year-old man was diagnosed with pneumonia and subsequently tested positive for COVID-19. He was transferred to the hospital on day 9 after symptom onset due to worsening respiratory distress and hypotension.
Disseminated Varicella-Zoster Virus Infection with Internal Organ Involvement: A Scoping Review of 156 Cases.
Viruses
August 2025
Department of Hospital Medicine, Mayo Clinic Health System, Eau Claire, WI 54703, USA.
Visceral disseminated varicella-zoster virus infection (VD-VZV) involves the hematogenous spread of VZV from the skin to the internal organs. Though rare, it is potentially life-threatening, predominantly affecting immunocompromised individuals. Diagnosis is often delayed due to nonspecific symptoms mimicking other viral illnesses.
View Article and Find Full Text PDFA Case of Hepatic Decompensation Caused by IgG4-positive Plasma Cell Infiltration Mimicking Sclerosing Cholangitis, Who Achieved a Four-year Survival by Glucocorticoid Treatment.
Intern Med
August 2025
Department of Gastroenterology and Hepatology, Kansai Medical University, Japan.
A 51-year-old man was referred to our hospital because of a worsening liver function after a follow-up of13 years for elevated hepatobiliary enzyme levels of unknown etiology. The IgG4 (4,990 mg/dL) levels were markedly elevated. Imaging revealed splenomegaly, intrahepatic bile duct dilatation, and an early enhancement area in the right lobe.
View Article and Find Full Text PDFIL6 genetic perturbation mimicking IL-6 inhibition is associated with lower cardiometabolic risk.
Nat Cardiovasc Res
August 2025
Institute for Stroke and Dementia Research, LMU University Hospital, LMU Munich, Munich, Germany.
Human genetics supports a causal involvement of IL-6 signaling in atherosclerotic cardiovascular disease, prompting the clinical development of anti-IL-6 therapies. Genetic evidence has historically focused on IL6R missense variants, but emerging cardiovascular treatments target IL-6, not its receptor, questioning the translatability of genetic findings. Here we develop a genetic instrument for IL-6 signaling downregulation comprising IL6 locus variants that mimic the effects of the anti-IL-6 antibody ziltivekimab and use it to predict the effects of IL-6 inhibition on cardiometabolic and safety endpoints.
View Article and Find Full Text PDF